Water Intake and Weight Control in Older Adults
- Conditions
- Overweight and Obesity
- Interventions
- Behavioral: Water intake and weight control in older adults - Premeal Water + hypocaloric dietBehavioral: Water Intake and weight control in older adults - hypocaloric diet aloneBehavioral: Water intake and weight control in older adults - Total Daily Water + hypocaloric diet
- Registration Number
- NCT05843318
- Brief Summary
This study is a randomized controlled intervention trial in adults aged 50+ years with overweight or obesity, which will compare three groups with different diet prescriptions: 1) pre-meal water consumption (500 ml, before each main meal) with a hypocaloric diet; 2) 1500 ml water consumed throughout the day with a hypocaloric diet; 3) hypocaloric diet with no instructions regarding water consumption. Smart water bottles will objectively assess water intake timing and volume. Urine osmolality, urine volume, and serum osmolality will be used as objective indicators of compliance with the water intake prescription. We will investigate changes in perceived hunger and fullness and appetite-regulating hormones as potential mechanisms by which premeal water could improve appetite regulation. We will also investigate the impact of water consumption and hydration on executive function capabilities, which may influence intervention adherence. Although increasing water intake could be an effective weight management strategy, no evidence-based recommendations exist for the timing of water intake needed for this benefit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 375
- aged 50+ years
- BMI ≥25 kg/m2
- weight stable (+/- 2 kg) in past 6 months
- willing to provide consent and comply with study protocol
- usual plain drinking water intake >1500 ml/d
- uncontrolled hypertension (>159/99 mmHg)
- medical condition requiring specialized diet prescription (eg, T2D, CHF wih fluid restriction)
- medical condition that precludes participating in a physical activity program (eg, orthopedic injury)
- current or history of GI disease (eg, Crohn's), GI surgery, or medications which impact GI function
- allergies or aversions to foods included in the test meals
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pre-meal water + Hypocaloric diet Water intake and weight control in older adults - Premeal Water + hypocaloric diet premeal water ( 500 ml) before each main meal, three times per day + hypocaloric diet Hypocaloric Diet alone Water Intake and weight control in older adults - hypocaloric diet alone hypocaloric diet with not instructions regarding water intake Daily water + Hypocaloric diet Water intake and weight control in older adults - Total Daily Water + hypocaloric diet total daily water prescription (1500 ml/d) + hypocaloric diet
- Primary Outcome Measures
Name Time Method Body weight change weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase Body weight change in weight loss and weight loss maintenance phases
- Secondary Outcome Measures
Name Time Method Change in hydration status weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase Changes in hydration status, assessed using urine and serum osmolality, urine specific gravity, and serum sodium, in weight loss and weight loss maintenance phases. These changes may mediate intervention adherence.
Change in appetite sensations weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase Changes in hunger and fullness, assessed using 100mm Visual Analog Scales (VAS), in weight loss and weight loss maintenance phases. These changes may mediate adherence to the hypocaloric diet and weight loss outcomes.
Change in executive function (EF) weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase Changes in EF (attention, inhibition) assessed using ePRIME computerized tasks, in weight loss and weight loss maintenance phases. These changes may mediate intervention adherence.
Trial Locations
- Locations (1)
Virginia Tech
🇺🇸Blacksburg, Virginia, United States